Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

被引：16

作者：

Liu, Yi-Chun Carol ^{[1
,2
]}

Ibekwe, Titus ^{[3
]}

Kelso, John M. ^{[4
]}

Klein, Nicola P. ^{[5
]}

Shehu, Nathan ^{[6
]}

Steuerwald, Wendy ^{[7
]}

Aneja, Satinder ^{[8
]}

Dudley, Matthew Z. ^{[9
,10
]}

Garry, Robert ^{[11
]}

Munoz, Flor M. ^{[12
,13
]}

机构：

[1] Baylor Coll Med, Dept Otorhinolaryngol, Houston, TX 77030 USA

[2] Texas Childrens Hosp, Houston, TX 77030 USA

[3] Univ Abuja, Dept Otorhinolaryngol, Abuja, Nigeria

[4] Scripps Clin, Div Allergy Asthma & Immunol, San Diego, CA USA

[5] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA

[6] Jos Univ, Dept Pediat Infect Dis, Jos, Nigeria

[7] Phoenix Childrens Hosp, Dept Audiol, Phoenix, AZ USA

[8] Sharda Univ, Sch Med Sci & Res, Dept Pediat, Gr Noida, India

[9] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA

[10] Johns Hopkins Univ, Inst Vaccine Safety, Bloomberg Sch Publ Hlth, Baltimore, MD USA

[11] Tulane Univ, New Orleans, LA 70118 USA

[12] Baylor Coll Med, Dept Pediat, Sect Infect Dis, Houston, TX 77030 USA

[13] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA

来源：

VACCINE | 2020年 / 38卷 / 30期

关键词：

Sensorineural hearing loss (SNHL); Hearing loss (HL); Adverse event; Adverse event of special interest (AESI); Adverse event following immunization (AEFI); Immunization; Vaccines; Guidelines; Case definition; IMPAIRMENT; PREVALENCE; CHILDREN; DEAFNESS; MANAGEMENT; METAANALYSIS; OTOTOXICITY; PROGRESSION; EFFICACY; HEALTH;

D O I：

10.1016/j.vaccine.2020.05.019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This is a Brighton Collaboration case definition of the term "Sensorineural Hearing Loss" to be utilized in the evaluation of adverse events following immunization. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for Lassa Fever and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and define levels of diagnostic certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network. (C) 2020 The Authors. Published by Elsevier Ltd.

引用

页码：4717 / 4731

页数：15

共 50 条

[1] Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation
Poli, Francesca
Overeem, Sebastiaan
Lammers, Gert Jan
Plazzi, Giuseppe
Lecendreux, Michel
Bassetti, Claudio L.
Dauvilliers, Yves
Keene, Daniel
Khatami, Ramin
Li, Yulin
Mayer, Geert
Nohynek, Hanna
Pahud, Barbara
Paiva, Teresa
Partinen, Markku
Scammell, Thomas E.
Shimabukuro, Tom
Sturkenboom, Miriam
van Dinthers, Kristy
Wiznitzer, Max
Bonhoeffer, Jan
[J]. VACCINE, 2013, 31 (06) : 994 - 1007
[2] Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation
Marcy, SM
Kohl, KS
Dagan, R
Nalin, D
Blum, M
Jones, MC
Hansen, J
Labadie, J
Lee, L
Martin, BL
O'Brien, K
Rothstein, E
Vermeer, P
[J]. VACCINE, 2004, 22 (5-6) : 551 - 556
[3] Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
Serazin, Nathan A.
Edem, Bassey
Williams, Sarah R.
Ortiz, Justin R.
Kawade, Anand
Das, Manoj Kumar
Subelj, Maja
Edwards, Kathryn M.
Parida, Shreemanta K.
Wartel, T. Anh
Munoz, Flor M.
Bastero, Patricia
[J]. VACCINE, 2021, 39 (22) : 3028 - 3036
[4] Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
Bonhoeffer, J
Menkes, J
Gold, MS
de Souza-Brito, G
Fisher, MC
Halsey, N
Vermeer, P
[J]. VACCINE, 2004, 22 (5-6) : 557 - 562
[5] Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
Rothstein, E
Kohl, KS
Ball, L
Halperin, SA
Halsey, N
Hammer, SJ
Heath, PT
Hennig, R
Kleppinger, C
Labadie, J
Varricchio, F
Vermeer, P
Walop, W
[J]. VACCINE, 2004, 22 (5-6) : 575 - 585
[6] Eczema vaccinatum as an adverse event following exposure to vaccinia virus: Case definition & guidelines of data collection, analysis, and presentation of immunization safety data
Nell, Patricia
Kohl, Katrin S.
Graham, Philip L.
LaRussa, Philip S.
Marcy, S. Michael
Fulginiti, Vincent A.
Martin, Bryan
Trolin, Ingrid
Norton, Scott A.
Neff, John M.
[J]. VACCINE, 2007, 25 (31) : 5725 - 5734
[7] Progressive vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data
Nell, Patricia
Kohl, Katrin S.
Graham, Philip L.
LaRussa, Philip S.
Marcy, S. Michael
Fulginiti, Vincent A.
Martin, Bryan
McMahon, Ann
Norton, Scott A.
Trolin, Ingrid
[J]. VACCINE, 2007, 25 (31) : 5735 - 5744
[8] Generalized vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Beigel, John
Kohl, Katrin S.
Brinley, Floyd
Graham, Philip L.
Khuri-Bulos, Najwa
LaRussa, Philip S.
Nell, Patricia
Norton, Scott
Stoltman, Gillian
Tebaa, Amina
Warschaw, Karen
[J]. VACCINE, 2007, 25 (31) : 5745 - 5753
[9] Inadvertent inoculation as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Wenger, Peter
Oleske, James M.
Kohl, Katrin S.
Fisher, Margaret C.
Brien, James H.
Graham, Philip L.
LaRussa, Philip S.
Lipton, Susan
Tierney, Bruce
[J]. VACCINE, 2007, 25 (31) : 5754 - 5762
[10] Anaphylaxis:: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Rueggeberg, Jens U.
Gold, Michael S.
Bayas, Jose-Maria
Blum, Michael D.
Bonhoeffer, Jan
Friedlander, Sheila
Brito, Glacus de Souza
Heininger, Ulrich
Imoukhuede, Babatunde
Khamesipour, Ali
Erlewyn-Lajeunesse, Michel
Martin, Susana
Makela, Mika
Nell, Patricia
Pool, Vitali
Simpson, Nick
[J]. VACCINE, 2007, 25 (31) : 5675 - 5684

← 1 2 3 4 5 →